Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)

ClinicalTrials.gov ID: NCT05202262

Public ClinicalTrials.gov record NCT05202262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel Group, Multicenter 24 Week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler and Open-Label Symbicort® Turbuhaler® in Participants With Inadequately Controlled Asthma (VATHOS).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 24 week study to evaluate the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma.

Study identification

NCT ID
NCT05202262
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
645 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2022 (Actual)
Primary completion
Feb 26, 2025 (Actual)
Completion
Feb 26, 2025 (Actual)
Last update posted
Jan 28, 2026

2022 – 2025

United States locations

U.S. sites
66
U.S. states
25
U.S. cities
59
Facility City State ZIP Site status
Research Site Chandler Arizona 85224 —
Research Site Tucson Arizona 85745 —
Research Site Bakersfield California 93301 —
Research Site Fresno California 93720 —
Research Site Huntington Beach California 92647 —
Research Site La Palma California 90623 —
Research Site Lincoln California 95648 —
Research Site Los Angeles California 90017 —
Research Site Los Angeles California 90025 —
Research Site Los Angeles California 90048 —
Research Site Newport Beach California 92663 —
Research Site Northridge California 91324 —
Research Site Sacramento California 95823 —
Research Site San Diego California 92120 —
Research Site San Diego California 92123 —
Research Site San Jose California 95117 —
Research Site Denver Colorado 80230 —
Research Site Wheat Ridge Colorado 80033 —
Research Site Cutler Bay Florida 33189 —
Research Site DeLand Florida 32720 —
Research Site Miami Florida 33155 —
Research Site Miami Florida 33173 —
Research Site Miami Florida 33175 —
Research Site Miami Florida 33180 —
Research Site Tampa Florida 33607 —
Research Site Atlanta Georgia 30361 —
Research Site Peoria Illinois 61636 —
Research Site Lexington Kentucky 40509 —
Research Site White Marsh Maryland 21162 —
Research Site North Dartmouth Massachusetts 02747 —
Research Site Farmington Hills Michigan 48336 —
Research Site Columbia Missouri 65203 —
Research Site Saint Charles Missouri 63301 —
Research Site St Louis Missouri 63141 —
Research Site Kalispell Montana 59901 —
Research Site Missoula Montana 59808 —
Research Site Bellevue Nebraska 68123 —
Research Site Omaha Nebraska 68114 —
Research Site Henderson Nevada 89052 —
Research Site North Las Vegas Nevada 89030 —
Research Site Portsmouth New Hampshire 03801 —
Research Site Skillman New Jersey 08558 —
Research Site Gastonia North Carolina 28054 —
Research Site Monroe North Carolina 28112 —
Research Site Raleigh North Carolina 27607 —
Research Site Cincinnati Ohio 45236 —
Research Site Columbus Ohio 43215 —
Research Site Edmond Oklahoma 73034 —
Research Site Oklahoma City Oklahoma 73120 —
Research Site Portland Oregon 97202 —
Research Site Pittsburgh Pennsylvania 15236 —
Research Site Knoxville Tennessee 37909 —
Research Site Austin Texas 78759 —
Research Site Beaumont Texas 77701 —
Research Site Boerne Texas 78006 —
Research Site Dallas Texas 75231 —
Research Site El Paso Texas 79912 —
Research Site Forney Texas 75126 —
Research Site Houston Texas 77093 —
Research Site Red Oak Texas 75154 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78258 —
Research Site Victoria Texas 77901 —
Research Site Waco Texas 76712 —
Research Site Williamsburg Virginia 23188 —
Research Site Milwaukee Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05202262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05202262 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →